Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MASIMO CORPORATION

(MASI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Masimo Corporation Rad-G? Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India

11/29/2021 | 02:00am EST

Masimo announced the findings of a study published in Clinical Medicine Insights: Pediatrics in which Dr. Harish Kumar and colleagues at IPE Global in New Delhi, India reported on their experience using the Masimo Rad-G? Pulse Oximeter to aid health providers in pneumonia case detection and management in more than 4,500 children under five years who presented with symptoms of acute respiratory infection (ARI). Rad-G is a rugged, portable, handheld Masimo SET? Measure-through Motion and Low Perfusion? pulse oximeter and noninvasive respiration rate monitor from the pleth (RRp?). The researchers found that Rad-G was ?highly acceptable among health workers? and aided the ?timely classification and treatment? of pneumonia?helping them achieve correct case management in more than 91% of cases of ARI and reduce the unnecessary use of antibiotics. As the authors note, pneumonia ? one of the most common causes of ARI in children ? contributes to 15% of child deaths across the world, with India accounting for 20% of those deaths. In low-resource health settings, where access to diagnostic aids is limited, health workers often rely on manual counts of respiratory rate to inform ARI management decisions. In this trial, researchers evaluated oxygen saturation (SpO2) and respiratory rate (in accordance with WHO guidelines for effective pneumonia management) measured by Rad-G. Given the often ?inadequate skills? of front-line healthcare workers in low-resource and rural settings?for example, it was found that the majority of workers at Indian Health and Wellness Centers (HWCs) ?lacked knowledge on how to correctly assess a child with cough or difficult breathing??the authors hoped that Rad-G could help workers more readily diagnose pneumonia, prove to offer good ?usability,? and ultimately, contribute to India?s goal of aggressively reducing child deaths due to pneumonia. The researchers chose Rad-G from among other available pulse oximeters for a variety of reasons, in particular its integration of respiration rate from the pleth (RRp) and accurate and reliable SpO2. Before proceeding with this larger trial, an initial study at a single tertiary care hospital was conducted in 2019 to evaluate the accuracy of RRp on Rad-G. That study found a 97% association between Rad-G RRp and pediatrician-measured RR, with high sensitivity, specificity, and accuracy.2 The authors also noted Rad-G?s long-lasting, rechargeable battery, its LCD display, and the fact that a single sensor could be used on all children under five years. Following the initial study, Rad-G was introduced at 19 HWCs across seven states in India, and its implementation and utility (including usability and durability) were tracked over 15 months, from June 2019 to August 2020. Over this period, a total of 4,846 children aged 2 ? 60 months with symptoms of ARI visited the facilities. To aid in assessing cases, providers were given abridged training in India?s Integrated Management of Neonatal and Childhood Illnesses (IMNCI) program, which classifies children with ARI as having severe pneumonia (SpO2


ę S&P Capital IQ 2021
All news about MASIMO CORPORATION
01/17Retrospective Study Finds That Masimo SET« Pulse Oximetry Has No Difference in Accuracy..
BU
01/14MASIMO : SECOND AMENDMENT TO THE NOVEMBER 4, 2015 AMENDED AND RESTATED EMPLOYMENT AGREEMEN..
PU
01/14MASIMO CORP : Change in Directors or Principal Officers (form 8-K)
AQ
01/12INSIDER SELL : Masimo
MT
01/11Masimo Issues Guidance for 2022, Reports Preliminary Results for 2021
MT
01/11Masimo Announces Select Preliminary Full-Year 2021 Financial Results and 2022 Guidance
BU
01/11MASIMO : Announces Select Preliminary Full-Year 2021 Financial Results and 2022 Guidance -..
PU
01/11MASIMO CORP : Results of Operations and Financial Condition (form 8-K)
AQ
01/11Masimo Corporation Provides Earnings Guidance for the Years 2021 and 2022
CI
2021MASIMO : Q3 2021 Supplemental Presentation to Earnings Press Release
PU
More news
Analyst Recommendations on MASIMO CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 233 M - -
Net income 2021 224 M - -
Net cash 2021 762 M - -
P/E ratio 2021 57,1x
Yield 2021 -
Capitalization 12 240 M 12 240 M -
EV / Sales 2021 9,31x
EV / Sales 2022 8,27x
Nbr of Employees 2 000
Free-Float -
Chart MASIMO CORPORATION
Duration : Period :
Masimo Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MASIMO CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 221,66 $
Average target price 298,20 $
Spread / Average Target 34,5%
EPS Revisions
Managers and Directors
Joe E. Kiani Chairman & Chief Executive Officer
Micah Young Chief Financial Officer & Executive Vice President
Yongsam Lee Chief Information Officer & Executive VP
Anand Sampath Executive VP-Operations & Clinical Research
Jon Curtis Coleman President-Worldwide Sales & Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
MASIMO CORPORATION-23.75%12 240
GETINGE AB-13.95%10 157
PENUMBRA, INC.-22.28%8 342
NOVOCURE LIMITED-6.63%7 278
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-14.52%5 045
ASAHI INTECC CO., LTD.-15.58%4 969